Baker McKenzie advises Galapagos on its acquisition of CellPoint and AboundBio | Newsroom
Both acquisitions will accelerate Galapagos' access to next generation cell therapies, significantly broaden their portfolio and will serve to ...
Source: bakermckenzie.com